127 related articles for article (PubMed ID: 37815682)
1. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Scheipner L; Barletta F; Cano Garcia C; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; Pichler M; Ahyai S; Karakiewicz PI
Ann Surg Oncol; 2023 Dec; 30(13):8780-8785. PubMed ID: 37815682
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lymph node count in surgically treated patients with T
Assad A; Barletta F; Incesu RB; Scheipner L; Morra S; Baudo A; Garcia CC; Tian Z; Ahyai S; Longo N; Chun FKH; Shariat SF; Tilki D; Briganti A; Saad F; Karakiewicz PI
Urol Oncol; 2024 Aug; 42(8):248.e1-248.e9. PubMed ID: 38653591
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.
Scheipner L; Incesu RB; Morra S; Baudo A; Assad A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; De Cobelli O; Pichler M; Ahyai S; Karakiewicz PI
Clin Genitourin Cancer; 2024 Apr; 22(2):164-170. PubMed ID: 37981546
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.
Barletta F; Tappero S; Morra S; Incesu RB; Cano Garcia C; Piccinelli ML; Scheipner L; Baudo A; Tian Z; Gandaglia G; Stabile A; Mazzone E; Terrone C; Longo N; Tilki D; Chun FKH; de Cobelli O; Ahyai S; Carmignani L; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2023 Dec; 21(6):e461-e466.e1. PubMed ID: 37365054
[TBL] [Abstract][Full Text] [Related]
5. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
[TBL] [Abstract][Full Text] [Related]
6. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
7. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
8. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
11. Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
Barletta F; Tappero S; Morra S; Incesu RB; Cano Garcia C; Piccinelli ML; Scheipner L; Tian Z; Gandaglia G; Stabile A; Mazzone E; Terrone C; Longo N; Tilki D; Chun FKH; de Cobelli O; Ahyai S; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
J Surg Oncol; 2024 Jun; 129(7):1305-1310. PubMed ID: 38470523
[TBL] [Abstract][Full Text] [Related]
12. The absence of lymph nodes removed (pNx status) impacts survival in patients with lung cancer treated surgically.
Cackowski MM; Gryszko GM; Zbytniewski M; Dziedzic M; Woźnica K; Orłowski TM; Dziedzic DA;
Surg Oncol; 2023 Jun; 48():101941. PubMed ID: 37023511
[TBL] [Abstract][Full Text] [Related]
13. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy.
Yang DY; Potretzke TA; Miest TS; Bhindi B; Lohse CM; Cheville JC; King BF; Boorjian SA; Leibovich BC; Thompson RH; Potretzke AM
Int J Urol; 2020 Jul; 27(7):618-622. PubMed ID: 32424856
[TBL] [Abstract][Full Text] [Related]
14. Lymph node count impacts survival following post-chemotherapy retroperitoneal lymphadenectomy for non-seminomatous testicular cancer: a population-based analysis.
Bhanvadia RR; Rodriguez J; Bagrodia A; Eggener SE
BJU Int; 2019 Nov; 124(5):792-800. PubMed ID: 31054211
[TBL] [Abstract][Full Text] [Related]
15. Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis.
Tappero S; Piccinelli M; Barletta F; Panunzio A; Cano Garcia C; Incesu RB; Tian Z; Parodi S; Dell'Oglio P; De Cobelli O; Briganti A; Antonelli A; Chun FKH; Graefen M; Saad F; Shariat SF; Suardi NR; Borghesi M; Terrone C; Karakiewicz PI
World J Urol; 2023 Jan; 41(1):119-125. PubMed ID: 36239810
[TBL] [Abstract][Full Text] [Related]
16. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic outcomes associated with lymph node examination status in early-stage non-small cell lung cancer: a real-world US study using the SEER-Medicare linked database.
Lee JM; To TM; Wang S; Lin CW; Johnson A; Meyer CS; Lee JS
Transl Cancer Res; 2024 Apr; 13(4):1821-1833. PubMed ID: 38737679
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.
Xiang M; Holsinger FC; Gensheimer MF; Divi V; Pollom EL; Colevas AD; Le QT; Beadle BM
Am J Clin Oncol; 2021 Mar; 44(3):99-104. PubMed ID: 33417322
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
